Hemodynamic Monitoring Devices will have significant change from previous year. By the most conservative estimates of global Hemodynamic Monitoring Devices market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 685.4 million in 2020. Over the next five years the Hemodynamic Monitoring Devices market will register a 2.3% CAGR in terms of revenue, the global market size will reach US$ 750.1 million by 2026.
Based on the Hemodynamic Monitoring Devices market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields of Life Sciences. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth of Hemodynamic Monitoring Devices during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
Hemodynamic Monitoring Devices Market highlights the potential growth opportunities in upcoming years, while reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape and other key aspects in the global market. The Global Hemodynamic Monitoring Devices Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry. This Research Study compares the markets of Pre COVID-19 and Post COVID-19 with the impact of COVID-19 on the regional economy.
The report also assesses the key opportunities in the Hemodynamic Monitoring Devices market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global Hemodynamic Monitoring Devices Market has also been forecasted for the period 2021-2026, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
EDWARDS MITRIS RESILIA VALVE RECEIVES FDA APPROVAL FOR MITRAL REPLACEMENT SURGERIES
IRVINE, Calif., March 31, 2022 -- Edwards Lifesciences (NYSE: EW) today announced it received approval from the U.S. Food and Drug Administration (FDA) for the MITRIS RESILIA valve, a tissue valve replacement specifically designed for the heart's mitral position.
The MITRIS RESILIA valve has a saddle-shaped sewing cuff that mimics the asymmetric shape of the native mitral valve. It also features a low-profile frame that helps avoid obstruction of the left ventricular outflow tract by stent posts and is visible under fluoroscopy, to facilitate potential future transcatheter interventions for patients. This therapy is the company's latest innovation offering advanced RESILIA tissue with an anti-calcification technology that also allows devices to be stored under dry packaging conditions, facilitating ease of use.
Hemodynamic Monitoring Devices Market is segmented based on the type, applications, companies and regions.
By Type, Hemodynamic Monitoring Devices Market has been segmented into
Noninvasive Hemodynamic Monitoring Devices
Minimally Invasive Hemodynamic Monitoring Devices
Invasive Hemodynamic Monitoring Devices
Others
The end user’s industry applications in Hemodynamic Monitoring Devices Market is,
Department of Cardiopulmonary
Department of Neurosurgery
ICU/CCU
Department of Emergency
Others
Regional Analysis:
According to Edwards Lifesciences Corporation's annual report, demand for its pressure monitoring products increased in the United States in 2020, and this trend continued through the fourth quarter. In 2021, as hospital capital spending continued to improve and COVID hospitalizations in the United States increased, there was an increase in demand for pressure monitoring.
North America currently dominates the market for hemodynamic monitoring and is expected to continue its stronghold for a few more years. The United States holds the largest share of the global hemodynamic monitoring market. The growth of the United States hemodynamic monitoring market is the most notable, owing to the presence of major market players, technologically advanced hospitals, and an increasing number of critically ill patients being treated in hospitals of the region.
The report incorporates in-depth assessment of the competitive landscape, product market sizing, product benchmarking, market trends, product developments, financial analysis, strategic analysis and so on to gauge the impact forces and potential opportunities of the market. Apart from this the report also includes a study of major developments in the market such as product launches, agreements, acquisitions, collaborations, mergers and so on to comprehend the prevailing market dynamics at present and its impact during the forecast period 2021-2026. The report presents the analysis of Hemodynamic Monitoring Devices Market for the historical period of 2017-2021 and the forecast period of 2021-2026.
Reports Attributes | Report Details |
Forecast Period 2022 to 2027 CAGR | CAGR of 2.3% during the review period (2022 to 2027). |
By Type |
|
By Application |
|
By Companies | Edwards Lifesciences Corporation (NYSE :EW), Koninklijke Philips N.V. (NYSE :PHG), ICU Medical, Panasonic, Cheetah Medical, GE, Nihon Kohden, Draeger, Schwarzer Cardiotek |
Regions Covered | • North America • Europe • Asia-Pacific • Rest of the World |
Countries Covered | • US • Canada • Germany • France • UK • Italy • Spain • Rest of Europe • China • Japan • India • Australia • South Korea • Rest of Asia-Pacific • Middle East & Africa • Latin America |
Base Year | 2022 |
Historical Year | 2017 to 2021 |
Forecast Year | 2022 to 2027 |
Number of Pages | 121 |
Customization Available | Yes, the report can be customized as per your needs |
All our reports are customizable to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report to your needs.
What is the study period of this market?
The Hemodynamic Monitoring Devices Market is studied from 2017 - 2027.
Who are the key players in Hemodynamic Monitoring Devices Market?
Edwards Lifesciences Corporation (NYSE :EW), Koninklijke Philips N.V. (NYSE :PHG), ICU Medical, Panasonic, Cheetah Medical, GE, Nihon Kohden, Draeger, Schwarzer Cardiotek, Getinge (Pulsion), Cnsystems, Mindray, LIDCO, Uscom, Deltex Medical, Osypka Medical, Baolihao and others..
What are the significant types of Hemodynamic Monitoring Devices Market?
Noninvasive Hemodynamic Monitoring Devices, Minimally Invasive Hemodynamic Monitoring Devices, Invasive Hemodynamic Monitoring Devices, Other
What are the major end-use applications of Hemodynamic Monitoring Devices Market?
Department of Cardiopulmonary, Department of Neurosurgery, ICU/CCU, Department of Emergency, Others
What segments are covered in the Hemodynamic Monitoring Devices Market report?
The Global Hemodynamic Monitoring Devices Market is Segmented on the basic of Product, Application, and Geography.
How can I get a sample report/company profile for the Hemodynamic Monitoring Devices Market?
The sample report for the Hemodynamic Monitoring Devices Market can be obtained on demand from the website. Also, the 24*7 chat support & direct call services are provided to procure the sample report.
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
Reach us with your research requirements and we shall provide the optimum solution to suit your needs.
Discounts available for multiple report purchases.